Health Condition 1: null- Chronic Heart Failure patients
Conditions
Interventions
Intervention1: Market approved St. Jude Medical
CRTD or CRTP device with no prior LV lead placement: Patients implanted with any market approved St. Jude Medical
CRTD or CRTP device with no prior LV l
Sponsors
St Jude Medical India Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Patient willing and able to sign informed consent and Patients implanted with any market approved St. Jude Medical CRTD or CRTP device with no prior LV lead placement
Exclusion criteria
Exclusion criteria: Are likely to undergo heart transplantation within the next 12 months Are less than 18 years of age Are pregnant or planning to become pregnant during the duration of the study Are currently participating in a clinical investigation that includes an active treatment arm 5. Have a life expectancy of less than 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of non-responders to CRT Timepoint: 3 to 4 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Commonly used definitions of response to CRT Treatment strategies employed to treat HF in the non-responder population Efficacy of treatment strategies used to treat non-responders Identification of the decision-making process in the care of non-responders Characterization of the management pathway and related therapies following declaration of non-response to CRT Role of remote-monitoring in treating and monitoring non-respondersTimepoint: 3 to 4 years | — |
Countries
China, India, Japan, United States of America
Contacts
Public ContactSumit Anand
St. Jude Medical India Pvt. Ltd
Outcome results
None listed